Thomas William Heitkemper, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1550 Yankee Park Pl, Ste A, Centerville Finance, OH 45458 Phone: 937-439-4949 Fax: 937-439-4948 |
Dr. Linda Whitley Reed, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 6728 Loop Rd, Buildiing 5 - Suite 204, Centerville Finance, OH 45459 Phone: 937-433-5601 Fax: 937-433-5605 |
Dr. Craig Douglas Olson, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 7071 Corporate Way, 7071 Corporate Way Suite106, Centerville Finance, OH 45459 Phone: 937-890-9804 Fax: 513-897-3821 |
News Archive
Unilens Vision Inc. today announced the Company completed the Stock Purchase Agreement announced on November 9, 2009, in which it repurchased 2,188,861 shares of its common stock, representing approximately 48% of it's outstanding shares, from its largest shareholder, Uniinvest Holding AG in Liquidation (Uniinvest) for an aggregate purchase price of US $6,894,912 or $3.15 per share.
Measles deaths have fallen by 60% worldwide since 1999 - a major public health success. This exceeds the United Nations goal to halve measles deaths between 1999 and 2005 and is largely due to an unprecedented decline in measles deaths in the African region.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it presented positive efficacy and safety data for its doxorubicin targeted conjugate compound, AEZS-108, in ovarian cancer.
The US Centers for Disease Control and Prevention (CDC) have now received information on 34 deaths and over 1,600 cases of e-cigarette, or vaping, product use associated lung injury (EVALI), as of October 22, 2019. This means over 120 new cases in just one week. The CDC has run a comprehensive analysis on 29 of the deaths.
Researchers at the Johns Hopkins Kimmel Cancer Center report that their study of tumor samples from people with the rare genetic syndrome neurofibromatosis type 1 (NF1) has uncovered novel molecular clues about which tumors are most likely to be aggressive in those with NF1
› Verified 3 days ago